Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
4 hedge funds and large institutions have $876K invested in Abeona Therapeutics Inc Warrant in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
68% less capital invested
Capital invested by funds: $2.74M → $876K (-$1.86M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$3.17K |
Top Sellers
ABEOW Hedge Fund Activity: Q2 2019 in Review
4 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q2 2019, worth a combined $876K — down 68% from $2.74M a quarter earlier.
Fund positioning in ABEOW was balanced in Q2 2019: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Wolverine Asset Management, adding an estimated $3.17K.
- 4 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $876K of Abeona Therapeutics Inc Warrant stock for Q2 2019, down 68% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q2 2019 and 0 closed out.
- The largest Abeona Therapeutics Inc Warrant buyer in Q2 2019 was Wolverine Asset Management, an estimated $3.17K added.
Based on aggregated 13F filings for Q2 2019.